Evidence map›Paper›PMID 26808227›Full record

ReviewBritish journal of pharmacology2016

On the different experimental manifestations of two-state 'induced-fit' binding of drugs to their cellular targets.

Georges Vauquelin, Isabelle Van Liefde, David C Swinney

Abstract readReview
In one paragraph

Review in British journal of pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Link between a highMedChemComm · 2018
    Review
  6. Article
  7. Drug-Target Kinetics in Drug Discovery.ACS chemical neuroscience · 2018
    Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Georges VauquelinDepartment of Molecular and Biochemical Pharmacology, Vrije Universiteit Brussel, Brussels, Belgium.
Isabelle Van LiefdeDepartment of Molecular and Biochemical Pharmacology, Vrije Universiteit Brussel, Brussels, Belgium.
David C SwinneyInstitute for Rare and Neglected Diseases Drug Discovery, Mountain View, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

'Induced-fit' binding of drugs to a target may lead to high affinity, selectivity and a long residence time, and this mechanism has been proposed to apply to many drugs with high clinical efficacy. It is a multistep process that initially involves the binding of a drug to its target to form a loose RL complex and a subsequent isomerization/conformational change to yield a tighter binding R'L state. Equations with the same mathematical form may also describe the binding of bivalent antibodies and related synthetic drugs. Based on a selected range of 'microscopic' rate constants and variables such as the ligand concentration and incubation time, we have simulated the experimental manifestations that may go along with induced-fit binding. Overall, they validate different experimental procedures that have been used over the years to identify such binding mechanisms. However, they also reveal that each of these manifestations only becomes perceptible at particular combinations of rate constants. The simulations also show that the durable nature of R'L and the propensity of R'L to be formed repeatedly before the ligand dissociates will increase the residence time. This review may help pharmacologists and medicinal chemists obtain preliminary indications for identifying an induced-fit mechanism.

Indexed as

Angiotensin II Type 1 Receptor BlockersAnimalsBinding SitesHumansLigandsReceptor, Angiotensin, Type 1Angiotensin II Type 1 Receptor BlockersLigandsReceptor, Angiotensin, Type 1

Identifiers

PMID26808227
PMCPMC4940813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.